Application no. and date | 14170999.8 (espacenet) (Federated) (European Patent Register), 20081117 | Patent/reg. no. and date | DK/EP 2818184, 20181031 | Publication date | 20141231 | Priority no. and date | US 988564 P, 20071116 | EP pub. no. and date |
EP 2818184 20141231 | Effective date | | Applicant/owner | Aclaris Therapeutics, Inc., 640 Lee Road Suite 200
Wayne, Pennsylvania 19087, US | Applicant ref. no. | P167321.DK.01/KERRS/LJUNGBERGR | Inventor | Shanler, Stuart D., 53 Underhill Drive
Pamona, NY New York 10970, US, Ondo, Andrew, 820 Canterbury Arc
Las Cruces, NM New Mexico 88005, US | Representative | Murgitroyd & Company, Mannerheimvägen 12 B 5th floor
FI-00100 Helsinki, FI | Opponent | | IPC Class | A61K 31/137 (2006.01) , A61K 31/4174 (2006.01) , A61K 31/498 (2006.01) , A61K 45/06 (2006.01) , A61P 17/00 (2006.01) | Title | Sammensætninger og fremgangsmåder til behandling af purpura | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|